Price Movement, page-145

I don't disagree with anything you've said here HR and you make a valid point on the screening process which would take my time-frame out another month.

My view remains that the temptation to post on social media during the Lavender trial will likely be overcome and confidentiality will be maintained.

However, when mothers know their daughters are receiving trofinetide during the Lilac study, given what happened in the phase 2 trial, when the same "rules" were be in place, I'm expecting we will get some exposure to the results they are seeing (in the event they are good).

Remember too, that when there was information distributed on social media in the phase 2 trial, the SP bounced significantly.